Aytu BioPharma, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
    • Specialty Pharmaceuticals
    • OTC, Consumer

Other Names/Subsidiaries

  • Aytu BioScience
  • ACerecor’s Paediatric Portfolio
  • Innovus Pharmaceuticals
  • Luoxis Diagnostics
  • Neos Therapeutics
  • Rosewind Corporation
  • Rumpus Therapeutics
  • Vyrix Pharmaceuticals
See more in Biomedtracker

Latest on Aytu BioPharma, Inc.

Generics Bulletin

Lupin Signs ADHD Drugs Deal With Aytu In Canada

 
• By Urtė Fultinavičiūtė

Indian giant Lupin has signed an exclusive deal with Aytu BioPharma , adding two drugs for the treatment of attention deficit hyperactivity disorder to its Canadian portfolio. The exclusive collabo

Scrip

Finance Watch: With Limited Fundraising Options, Biotechs Restructure To Extend Cash Runways

 
• By Mandy Jackson

Bogged down by an ongoing spat with its largest shareholder and a share price that continues to flirt with penny stock territory, Mereo BioPharma Group plc announced an updated operating plan on 18

Scrip

Deal Watch: Gain To Test Enzyme-Enhancement Tech In Cancer With Zentalis

 
• By Joseph Haas and Ian Haydock

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gain, Zentalis Hope To Find Protein Mis

Pink Sheet

US FDA Converges With Other Regulators On Insomnia Drug Warnings, But Broader Safety Disagreements Persist

 
• By Michael Cipriano

Despite a broader trend of disagreement among national pharma regulators over instances for which to issue drug safety alerts, there appears to be some degree of convergence on warnings regarding cert